Cervicovaginal interleukin-6, tumor necrosis factor-α, and interleukin-2 receptor as markers of preterm delivery

Clinical Chemistry

Volumn 50, Issue 10, 2004, Pages 1839-1842

  Grenache, David G ^a,b   Hankins, Kelly ^a   Parvin, Curtis A ^a   Gronowski, Ann M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREMATURE LABOR; PROTEIN DETERMINATION; UTERINE CERVIX; VAGINA SECRETION;

BIOLOGICAL MARKERS; BODY FLUIDS; CERVIX UTERI; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; RECEPTORS, INTERLEUKIN-2; RETROSPECTIVE STUDIES; VAGINA;

EID: 4644297614     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.034280     Document Type: Article

References (26)

1. Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD. Births: final data for 2001. Natl Vital Stat Rep 2002;51:1-102.
2. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339:313-20.
3. Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999;27:5-20.
4. Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141-5.
5. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997;177:13-8.
6. Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989;37:13-22.
7. Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:336-41.
8. Murtha AP, Greig PC, Jimmerson CE, Herbert WN. Maternal serum interleukin-6 concentration as a marker for impending preterm delivery. Obstet Gynecol 1998;91:161-4.
9. Greig PC, Murtha AP, Jimmerson CJ, Herbert WN, Roitman-Johnson B, Allen J. Matemal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet Gynecol 1997;90:465-9.
10. Alvarez-de-la-Rosa M, Rebollo FJ, Codoceo R, Gonzalez GA. Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery. Eur J Obstet Gynecol Reprod Biol 2000;88:57-60.
11. Greig PC, Emest JM, Teot L, Erikson M, Talley R. Amniotic fluid interleukin-6 levels correlate with histologic chodoamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol 1993;169:1035-44.
12. Maymon E, Ghezzi F, Edwin SS, Mazor M, Yoon BH, Gomez R, et al. The tumor necrosis factor α and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 1999;181:1142-8.
13. Matsuura H, Takio K, Titani K, Greene T, Levery SB, Salyan ME, et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem 1988;263:3314-22.
14. Coleman MA, Keelan JA, McCowan LM, Townend KM, Mitchell MD. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1β, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol 2001;95:154-8.
15. Lange M, Chen FK, Wessel J, Buscher U, Dudenhausen JW. Elevation of interleukin-6 levels in cervical secretions as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2003;82:326-9.
16. LaShay N, Gilson G, Joffe G, Qualls C, Curet L. Will cervicovaginal interleukin-6 combined with fetal fibronectin testing improve the prediction of preterm delivery? J Matern Fetal Med 2000;9:336-41.
17. Kurkinen-Raty M, Ruokonen A, Vuopala S, Koskela M, Rutanen EM, Karkkainen T, et al. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. BJOG 2001;108:875-81.
18. Trebeden H, Goffinet F, Kayem G, Maillard F, Lemoine E, Cabrol D, et al. Strip test for bedside detection of interleukin-6 in cervical secretions is predictive for impending preterm delivery. Eur Cytokine Netw 2001;12:359-60.
19. Jun JK, Yoon BH, Romero R, Kim M, Moon JB, Ki SH, et al. Interleukin 6 determinations in cervical fluid have diagnostic and prognostic value in preterm premature rupture of membranes. Am J Obstet Gynecol 2000;183:868-73.
20. Kishida T, Yamada H, Furuta I, Kobayashi N, Hirayama EK, Ebina Y, et al. Increased levels of interleukin-6 in cervical secretions and assessment of the uterine cervix by transvaginal ultrasonography predict preterm premature rupture of the membranes. Fetal Diagn Ther 2003;18:98-104.
21. Adeza Biomedical Corporation. Rapid fFN cassette. Sunnyvale, CA: Adeza Biomedical Corporation, 1999.
22. Lockwood CJ, Ghidini A, Wein R, Lapinski R, Casal D, Berkowitz RL. Increased interleukin-6 concentrations in cervical secretions are associated with preterm delivery. Am J Obstet Gynecol 1994;171:1097-102.
23. Diagnostics Products Corporation. Immulite IL-6. Los Angeles, CA: Diagnostics Products Corporation, 2000.
24. Diagnostics Products Corporation. Immulite TNFα. Los Angeles, CA: Diagnostics Products Corporation, 2002.
25. Diagnostics Products Corporation. Immulite IL2R. Los Angeles, CA: Diagnostics Products Corporation, 2002.
26. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, et al. Detection of tumor necrosis factor-α, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994;171:5-10.